The Recall Desk
SevereFDA (Drugs)·D-1235-2016·Announced 2016-07-20

Medaus Recalls Pyridoxine HCL Vials Due to Sterility Concerns

Medaus, Inc. is recalling Pyridoxine HCL 100mg/mL vials because the company cannot assure the sterility of the product.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. Under the rubric, FDA Class II recalls involving significant risks such as sterility issues in injectable products are categorized as Severe.

Plain-English summary

Medaus, Inc. is recalling Pyridoxine HCL 100mg/mL (PF) in 2 mL and 5 mL vials. The recall is being conducted because the company lacks assurance of the sterility of the product.

The affected product includes Lot # 160126-20 with a beyond-use date of 07/24/16. The total quantity involved is 2,000 mL in vials. The product was distributed in the United States, Japan, and New Zealand.

Consumers and healthcare providers should stop using the affected vials and contact Medaus, Inc. for further instructions or a refund.

The recalled product

Product
PYRIDOXINE HCL 100MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY
Manufacturer
Medaus, Inc.
Category
Drug — Injectable
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • a) Lot #: 160126-20
  • BUD: 07/24/16. b) Lot #: 160126-20
  • BUD: 07/24/16.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 88 recalled by Medaus, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 88 products in this recall →

Related recalls

Same manufacturer · Medaus, Inc.

See all →

Same hazard · sterility

See all →